METABOLISM AND DISPOSITION OF AMIFLOXACIN IN LABORATORY-ANIMALS

被引:13
作者
JOHNSON, JA
BENZIGER, DP
机构
关键词
D O I
10.1128/AAC.27.5.774
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:774 / 781
页数:8
相关论文
共 9 条
[1]   DISPOSITION O ARILDONE, AN ANTIVIRAL AGENT, AFTER VARIOUS ROUTES OF ADMINISTRATION [J].
BENZIGER, DP ;
EDELSON, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (03) :475-481
[2]  
GOUEFFON Y, 1981, CR ACAD SCI III-VIE, V292, P37
[3]   ABSORPTION AND EXCRETION OF MILOXACIN IN MICE, RATS, AND DOGS [J].
IZAWA, A ;
YOSHITAKE, A ;
KOMATSU, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (01) :41-44
[4]   ANALYSIS OF AMIFLOXACIN IN PLASMA AND URINE BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY AND INTRAVENOUS PHARMACOKINETICS IN RHESUS-MONKEYS [J].
MCCOY, LF ;
CRAWMER, BP ;
BENZIGER, DP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) :769-773
[5]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF PEFLOXACIN AND ITS MAIN ACTIVE METABOLITES IN BIOLOGICAL-FLUIDS [J].
MONTAY, G ;
BLAIN, Y ;
ROQUET, F ;
LEHIR, A .
JOURNAL OF CHROMATOGRAPHY, 1983, 272 (02) :359-365
[6]   ABSORPTION, DISTRIBUTION, METABOLIC-FATE, AND ELIMINATION OF PEFLOXACIN MESYLATE IN MICE, RATS, DOGS, MONKEYS, AND HUMANS [J].
MONTAY, G ;
GOUEFFON, Y ;
ROQUET, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) :463-472
[7]  
NAGATSU Y, 1981, CHEMOTHERAPY TOKY S4, V29, P119
[8]   INVITRO SUSCEPTIBILITIES OF 393 RECENT CLINICAL ISOLATES TO WIN-49375, CEFOTAXIME, TOBRAMYCIN, AND PIPERACILLIN [J].
POHLOD, DJ ;
SARAVOLATZ, LD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :377-379
[9]   NOVEL AMINO-SUBSTITUTED 3-QUINOLINECARBOXYLIC ACID ANTIBACTERIAL AGENTS - SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIPS [J].
WENTLAND, MP ;
BAILEY, DM ;
CORNETT, JB ;
DOBSON, RA ;
POWLES, RG ;
WAGNER, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (09) :1103-1108